ChrA is a response regulator (RR) in the two-component system involved in regulating the degradation and transport of haem (Fe-porphyrin) in the pathogen Corynebacterium diphtheriae. Here, the crystal structure of full-length ChrA is described at a resolution of 1.8 Å . ChrA consists of an N-terminal regulatory domain, a long linker region and a C-terminal DNA-binding domain. A structural comparison of ChrA with other RRs revealed substantial differences in the relative orientation of the two domains and the conformation of the linker region. The structural flexibility of the linker could be an important feature in rearrangement of the domain orientation to create a dimerization interface to bind DNA during haem-sensing signal transduction. research communications Acta Cryst. (2015). F71, 966-971 Doi et al. Corynebacterium diphtheriae response regulator ChrA 971
Introduction
Two-component signal transduction systems (TCSs) are ubiquitous in bacteria, fungi and plants. These systems can sense a variety of environmental changes in stimuli such as osmolarity, redox state, envelope stress, concentrations of metal ions etc. in order to adapt the cells to new environments by regulating the expression of their related genes (Stock et al., 2000) . In response to stimuli, the sensor histidine kinase (HK) in a TCS uses ATP to autophosphorylate its conserved His residue, and the phosphoryl group is then transferred to a conserved Asp residue in a cognate response regulator (RR). The phosphorylated RR is dimerized and then can bind to DNA as a transcriptional factor to promote its target gene.
In the present study, we focused on the RR of a haemsensing TCS in the Gram-positive bacterium Corynebacterium diphtheriae, which causes respiratory disease. C. diphtheriae has two proteins in its haem-sensing TCS, ChrS and ChrA, which are responsible for iron uptake and utilization (Schmitt, 1999) , since the pathogen acquires iron from the haem (Feporphyrin compound) in the haemoglobin of a host for the expression of the diphtheria toxin as well as for cell survival (Litwin & Calderwood, 1993; Schmitt, 1997; Schmitt & Holmes, 1991; Wandersman & Delepelaire, 2004) . ChrS is a sensor HK (Ito et al., 2009) and ChrA is a cognate RR. The activated ChrA specifically binds to either the hmuO or hrtAB promoter regions to promote the transcription of the genes that encode the haem oxygenase and the ABC-type haem exporter, respectively (Bibb et al., 2005; Burgos & Schmitt, 2012) .
Sequence analysis of ChrA shows that it belongs to the NarL/FixL subfamily of RRs consisting of N-terminal regulatory and C-terminal DNA-binding domains (Burgos & Schmitt, 2012) . Several full-length crystal structures of NarL/ FixJ family members have been determined and showed conserved folds in each domain, but with various relative ISSN 2053-230X # 2015 International Union of Crystallography orientations of the two domains (Baikalov et al., 1996; Leonard et al., 2013; Milani et al., 2005; Park et al., 2013) . The C-terminal DNA-binding domain contains a single helix-turnhelix (HTH) motif in the middle of a four-helix bundle (Baikalov et al., 1996) . The crystal structures of phosphorylated and unphosphorylated forms of the regulatory domain of FixJ (FixJn), which is involved in regulating the nitrogenfixation gene, revealed the structural basis for the conformational change of the residues of the regulatory domain during phosphorylation (PDB entries 1dck and 1d5w; Birck et al., 1999) . In addition, the structure of the DNA-bound form of the C-terminal domain of NarL revealed details of the DNArecognition and dimerization interface (PDB entry 1je8; Gao & Stock, 2009; Maris et al., 2002) . Despite these revelations on the structures of isolated domains, structural details of how the phosphorylation of an N-terminal regulatory domain regulates the behaviour of the C-terminal DNA-binding effector domain remain unclear.
In the present study, we report the full-length structure of ChrA at 1.8 Å resolution in an unphosphorylated state. The structure showed domain orientations and a linker conformation that differed from those of other members of the NarL/FixJ family. Structural comparisons of phosphorylation sites and interdomain interactions provided further insight into the activation mechanisms of ChrA on domain rearrangement and conformational change in the linker region, which would create an interface for dimerization and DNA binding.
Materials and methods

Expression and purification of ChrA
The ChrA gene was isolated from a C. diphtheriae C7(À) genome that was provided by Dr Iwaki (National Institute of Infectious Diseases, Japan) and was then ligated into modified pGEX6P-1. An expression plasmid (pChrA-C7) was introduced into Escherichia coli strain BL21(DE3)pLysS and the transformed cells were spread onto an LB agar plate with 50 mg ml À1 ampicillin and 34 mg ml À1 chloramphenicol. A single colony was inoculated into the LB medium and grown via a rotary shaker at 37 C overnight. The cells were transferred into 1 l Terrific Broth and grown at 25 C. The expression of ChrA was induced using isopropyl -d-1-thiogalactopyranoside and the cells were further grown overnight. The cultured cells were harvested by centrifugation (8000g, 15 min, 4 C) and stored at À80 C. The cell pellet was resuspended in lysis buffer (50 mM Tris-HCl pH 7.5, 50 mM NaCl, 5 mM EDTA), disrupted by sonication and centrifuged at 40 000 rev min À1 (Hitachi P45AT rotor) for 30 min at 4 C. The supernatant was purified using a GSTrap FF column and an Ä KTA system (GE Healthcare). The column was washed with wash buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA) followed by elution buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 10 mM reduced glutathione). The eluted sample was digested by PreScission protease (GE Healthcare) during dialysis in dialysis buffer [50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.01%(v/v) Tween-20] both with and without Tween-20. The dialyzed sample was loaded onto the GSTrap column and the flowthrough fraction was collected and concentrated with Centriprep YM-10 (Merck Millipore) to a concentration of 10 mg ml À1 . The purified protein contained residues 2-199 of ChrA and five extra residues (Gly-Pro-Leu-Gly-Ser) of a cloning artifact instead of the initial methionine at the N-terminus of ChrA.
Analytical size-exclusion chromatography
ChrA solution (10 mg ml À1 ) was analyzed using a Superdex 200 5/150 GL column (GE Healthcare) at a flow rate of 0.1 ml min À1 using an injection volume of 15 ml in buffer consisting of 25 mM Tris-HCl pH 7.8, 150 mM NaCl. The column was calibrated using gel-filtration standards from Bio-Rad. The apparent molecular weight was determined using the elution volume of the protein and the calculated calibration curve.
Crystallization, X-ray data collection and structure determination
The crystallization of purified ChrA was screened using commercially available screening kits. A hit condition, No. 20 from Crystal Screen 2 (Hampton Research), was optimized to 0.1 M MES pH 6.5, 1.6-1.7 M magnesium sulfate using the sitting-drop vapour-diffusion method at 4 C. The crystals belonged to space group I4 1 22, with unit-cell parameters 
is the observed intensity for reflection hkl and hI(hkl)i is the average intensity over symmetry-related and equivalent reflections. ‡ R work = P hkl jF obs j À jF calc j = P hkl jF obs j, where F obs and F calc are the observed and calculated structure-factor amplitudes for reflection hkl. R work was calculated for 95% of reflections used for structure refinement. R free was calculated for the remaining 5% of reflections that were randomly selected and excluded from refinement. a = b = 84.88, c = 169.30 Å . The crystals were cryoprotected by transferring them into a buffer consisting of the reservoir solution with an additional 30% glycerol. X-ray diffraction data were collected on BL41XU at SPring-8, Japan. The diffraction images were collected at 1 Å wavelength as a total of 170 images in rotation steps of 1 . All data were integrated and scaled using the HKL-2000 program suite (Otwinowski & Minor, 1997) . The initial phase was obtained via the molecular-replacement (MR) method. The coordinates of the NarL receiver domain from Mycobacterium tuberculosis (PDB entry 3eul; Schnell et al., 2008) gave the best results as a model in an automatic search for homologous models using BALBES (Long et al., 2008) . The MR phase was improved by DM (Cowtan, 1994) and was then used to build the model using ARP/wARP (Langer et al., 2008) . The model was manually rebuilt by Coot (Emsley & Cowtan, 2004) and refined by REFMAC5 (Murshudov et al., 2011) using the 1.8 Å resolution data. The statistical results of the X-ray data collection and structure refinement are shown in Table 1 .
Results
Overall structure of ChrA
Full-length ChrA crystallized in space group I4 1 22 with one monomer in the asymmetric unit. The packing arrangement in the crystal implied no possibility of dimer formation of ChrA when using our crystallization conditions. Size-exclusion chromatography also suggested that ChrA is a monomer in solution (Fig. 1) . ChrA consists of two domains: an N-terminal regulatory domain (ChrAn) consisting of residues 1-116, which contains the conserved Asp (Asp50) as the phosphoacceptor residue, and a C-terminal DNA-binding domain (ChrAc) consisting of residues 141-199 as an effector domain (Fig. 2) . The two domains are connected by a long linker (117-140) that contains a short -strand (6; 119-120) followed by a helix (6; 122-131) and a loop of nine residues (132-140). The 6 strand in the N-terminal portion of the linker region interacts with the 5 strand of the regulatory domain through hydrogen bonds to join the -sheet in the core of the regulatory domain. The 6 helix in the linker also makes contact with the regulatory domain through hydrophobic and hydrophilic interactions.
The most characteristic feature observed in our ChrA structure was the linearly extended structure of the loop in the C-terminal portion of the linker region, which is characterized by an absence of interactions between the regulatory and the DNA-binding domains. Indeed, the unique structural characteristics of ChrA are clearly manifested in structural comparisons with the overall structures of other structurally characterized full-length RRs of NarL/FixJ family members ( Fig. 3) : in Escherichia coli NarL is involved in nitrate/nitrite signal transduction (39% sequence identity; PDB entry 1rnl; Baikalov et al., 1996) , in Staphylococcus aureus VraR is involved in vancomycin resistance-associated responses (34% sequence identity; PDB entry 4gvp; Leonard et al., 2013) , in Streptococcus pneumoniae spr1814 is involved in the gene regulation of antibiotic transporters (26% sequence identity; PDB entry 4hye; Park et al., 2013) and in Pseudomonas fluorescens StyR is involved in styrene catabolism (34% sequence identity; PDB entry 1yio; Milani et al., 2005) . Each of the regulatory and DNA-binding domains in the RRs of this family shows topologically similar structures (see below), but the relative orientations of the two domains and the conformations of the linker regions differ substantially among them. For example, NarL and VraR have an L-shaped linker which consequently creates a widely extended interface between the two domains. In spr1814 the relative orientation of the two domains and the conformation of the N-terminal portion of loop. This irregular linking structure of StyR results in a relative domain orientation that is distinct from that of ChrA. These structural comparisons showed that our ChrA structure is uniquely able to provide novel information about the functional mechanism of the RR in a TCS.
C-terminal DNA-binding domain of ChrA (ChrAc)
ChrAc consists of 58 residues and folds into an apparent four-helix bundle (7-10; Fig. 2 ). The interfaces between these helices consist mostly of hydrophobic residues, and 8-9 form a conventional helix-turn-helix (HTH) motif for DNA binding. We predicted that when the phosphorylationactivated ChrA binds to DNA as a dimer, the recognition helix in the HTH motif would be inserted into the major groove and helix 10 and the 7-8 loop region would make up the dimerization interface (Maris et al., 2002) . In our ChrA structure neither the dimerization interface nor the DNAbinding sites were blocked by either the regulatory domain or the linker region.
The structure of ChrAc is very similar to those of other members of the FixL/NarL family, such as NarL, VraR, spr1814 and StyR, which can be superimposed with r.m.s.d.s for C atoms of 1.6, 0.8, 1.2 and 1.4 Å , respectively. Like ChrA, the crystal structure of StyR showed that the DNA-binding and dimerization interface of the DNA-binding domain are exposed to the solvent. In contrast, NarL and VraR exhibited access to the HTH that was sterically blocked by their N-terminal regulatory domains. The ChrAc structure observed in our ChrA crystal presumably reflects the structural characteristics before the dimerization of an RR when binding to DNA.
The N-terminal regulatory domain of ChrA (ChrAn)
ChrAn also exhibits the conserved tertiary structure of an RR with an / fold (Fig. 2) . However, by comparison with a typical regulatory domain structure (e.g. FixJn; five -helices and one -sheet consisting of five -strands; PDB entry 1d5w; Birck et al., 1999) , the helix 2 region of ChrA forms a loop structure rather than a helix owing to the deletion of four residues (Fig. 4a) .
The phosphorylation site of ChrAn, the conserved Asp50, is located at the C-terminal end of strand 3 of the regulatory domain and is exposed to the solvent in the present structure (Fig. 4b) . In our high-resolution structure of ChrA, the Asp50 carboxylate, together with one water molecule, bridges the distance (4 Å ) between the sulfate ion (SO 4 2À ) and the magnesium ion (Mg 2+ ). Mg 2+ is present in an octahedral coordination geometry involving the side chains of Asp8, His10 and Asp50 and three water molecules, where Asp8 is also highly conserved as an acidic residue in the NarL/FixJ family. On the other hand, the binding of SO 4 2À is stabilized through interactions with four residues (Gln52, Thr77, Thr81 and Lys99), which, except for Thr81, are also highly conserved. As shown in Fig. 4(a) , the SO 4 2À -bound state of ChrAn is reminiscent of phosphorylated FixJn (Birck et al., 1999) . The position of SO 4 2À and its interaction with Thr77 and Lys99 in ChrA are similar to those observed in the phosphorylated form of FixJ, i.e. the position of the phosphate group (-PO 4 ) and its interaction with Thr82 and Lys104 (Birck et al., 1999) .
Discussion
With respect to the activation of the RR in a TCS, the phosphorylation of the conserved Asp in the regulatory domain is thought to induce the dimerization of the RR, and the DNA- binding domain in the resultant dimerized RR binds to the target DNA to promote gene expression. This phosphorylationtriggered mechanism is possibly applicable to C. diphtheriae ChrA. The local structure of our ChrAn in the SO 4 2À -bound form apparently mimics that of the RR regulatory domain of the phosphate-bound form (Fig. 4a ), but ChrA in this state is a monomer (Fig. 2) . The effect of the SO 4 2À binding to ChrAn is probably localized and it cannot induce further conformational change for the dimerization of ChrA. The dimer formation of ChrA may be controlled by other specific interactions between phosphate groups covalently linked to Asp50 and surrounding residues, which would induce a conformational change around the dimerization interface.
Based on comparisons with the dimeric structure of phosphorylated FixJn, the 4-5 region is considered to be a dimerization interface of the regulatory domain. On the other hand, another dimerization interface (1 and 5) has been proposed from the recent structural analysis of beryllofluoride-activated VraR (Leonard et al., 2013) . In addition, the crystal packing of spr1814 suggested another interface consisting of the 4 helix, the 5-6 loop and a portion of the linker helix 6 (Park et al., 2013) . Although the present structure of ChrA in a monomeric state cannot provide direct information on the dimerization interface, our structural data for ChrA suggest that conformational change of 4-5 following phosphorylation of Asp50 might affect the conformation of the linker region, since 4-5 directly interacts with it. The most flexible position in a linker can be found at Pro135-Arg136, which exhibits a higher temperature factor (average 26.5 Å 2 ) relative to other main-chain atoms (average of 13.7 Å 2 ). This observation suggests that this position can act as one of the hinges that enable the protein to undergo largescale conformational changes for the dimerization and the relative orientation of domains.
In the present study, we revealed the high-resolution structure of an RR in the haem-sensor system of a C. diphtheriae TCS. On the basis of the structural characterization, it was suggested that dynamic motion of the two domains was essential for conversion to the active form upon activation via phosphorylation of the conserved Asp, and that the conformational flexibility of the linker region must play a key role in interdomain and intermolecular interactions. From this point of view, our structure of ChrA could amount to a snapshot of the interconversion of the active and inactive forms of an RR.
